Search

Your search keyword '"Herman F. Staats"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Herman F. Staats" Remove constraint Author: "Herman F. Staats" Topic biology.protein Remove constraint Topic: biology.protein
48 results on '"Herman F. Staats"'

Search Results

1. Lung-selective Cas13d-based nanotherapy inhibits lethal SARS-CoV-2 infection by targeting host protease Ctsl

2. Nasal Immunization With Small Molecule Mast Cell Activators Enhance Immunity to Co-Administered Subunit Immunogens

Catalog

Books, media, physical & digital resources

3. Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)

4. Fecal IgA, Antigen Absorption, and Gut Microbiome Composition Are Associated With Food Antigen Sensitization in Genetically Susceptible Mice

5. Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models

6. Optimized Mucosal MVA Prime/ Soluble gp120 Boost Vaccination Regimen Induces Similar Antibody Responses as an Intramuscular Regimen

7. Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellers

8. Perivascular dendritic cells elicit anaphylaxis by relaying allergens to mast cells via microvesicles

9. A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen

10. Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast Milk

11. Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy

12. Maximal Adjuvant Activity of Nasally Delivered IL-1α Requires Adjuvant-Responsive CD11c+ Cells and Does Not Correlate with Adjuvant-Induced In Vivo Cytokine Production

13. Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1

14. Immunization with the Haemophilus ducreyi Hemoglobin Receptor HgbA with Adjuvant Monophosphoryl Lipid A Protects Swine from a Homologous but Not a Heterologous Challenge

15. Development of a Bead Immunoassay To Measure Vi Polysaccharide-Specific Serum IgG after Vaccination with the Salmonella enterica Serovar Typhi Vi Polysaccharide

16. Mast Cells Augment Adaptive Immunity by Orchestrating Dendritic Cell Trafficking through Infected Tissues

17. Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigen

18. In Vitro and In Vivo Characterization of Anthrax Anti-Protective Antigen and Anti-Lethal Factor Monoclonal Antibodies after Passive Transfer in a Mouse Lethal Toxin Challenge Model To Define Correlates of Immunity

19. Immunization with the Haemophilus ducreyi trimeric autotransporter adhesin DsrA with alum, CpG or imiquimod generates a persistent humoral immune response that recognizes the bacterial surface

20. Effect of particulate adjuvant on the anthrax protective antigen dose required for effective nasal vaccination

21. Mucosal and systemic adjuvant activity of alphavirus replicon particles

22. A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques

23. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity

24. Mucosal Immunization of Lactating Female Rhesus Monkeys with a Transmitted/Founder HIV-1 Envelope Induces Strong Env-Specific IgA Antibody Responses in Breast Milk

25. The V3 Domain of SIVmac251 gp120 Contains a Linear Neutralizing Epitope

26. Effect of bismuth salts on systemic and mucosal immune responses to orally administered cholera toxin

27. Evaluation of vaccine-induced antibody responses: impact of new technologies

28. Stable Dry Powder Formulation for Nasal Delivery of Anthrax Vaccine

29. Mucosal targeting of a BoNT/A subunit vaccine adjuvanted with a mast cell activator enhances induction of BoNT/A neutralizing antibodies in rabbits

30. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues

31. Genetic determinants of immune-response to a polysaccharide vaccine for typhoid

32. The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen

33. Nonmucosal alphavirus vaccination stimulates a mucosal inductive environment in the peripheral draining lymph node

34. The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines

35. Effective Antibody Therapy in Herpes Simplex Virus Ocular Infection

36. Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination

37. Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies

38. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection

39. Detection of mucosal antibodies in HIV type 1-infected individuals

40. Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization

41. Epitope maps of the Escherichia coli heat-labile toxin B subunit for development of a synthetic oral vaccine

42. Vaccines for Selective Induction of Th1- and Th2-Cell Responses and Their Roles in Mucosal Immunity

43. Oral vaccine models: multiple delivery systems employing tetanus toxoid

44. Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin

45. Scarcity or Absence of Humoral Immune Responses in the Plasma and Cervicovaginal Lavage Fluids of Heavily HIV-1-Exposed But Persistently Seronegative Women

46. Anti-glycoprotein D monoclonal antibody protects against herpes simplex virus type 1-induced diseases in mice functionally depleted of selected T-cell subsets or asialo GM1+ cells

47. The common mucosal immune system: from basic principles to enteric vaccines with relevance for the female reproductive tract

48. Identification of recombinant antibodies against multiple distinct toll-like receptors by homolog mining a single immune scFv phage library